Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf

IMP/GMP preferring cytosolic 5'-nucleotidase II (cN-II) is a bifunctional enzyme whose activities and expression play crucial roles in nucleotide pool maintenance, nucleotide-dependent pathways and programmed cell death. Alignment of primary amino acid sequences of cN-II from human and other organisms show a strong conservation throughout the entire vertebrata taxon suggesting a fundamental role in eukaryotic cells. With the aim to investigate the potential role of this homology in protein-protein interactions, a two hybrid system screening of cN-II interactors was performed in S. cerevisiae. Among the X positive hits, the Leucin Rich Repeat (LRR) domain of Ipaf was found to interact with cN-II. Recombinant Ipaf isoform B (lacking the Nucleotide Binding Domain) was used in an in vitro affinity chromatography assay confirming the interaction obtained in the screening. Moreover, co-immunoprecipitation with proteins from wild type Human Embryonic Kidney 293 T cells demonstrated that endogenous cN-II co-immunoprecipitated both with wild type Ipaf and its LRR domain after transfection with corresponding expression vectors, but not with Ipaf lacking the LRR domain. These results suggest that the interaction takes place through the LRR domain of Ipaf. In addition, a proximity ligation assay was performed in A549 lung carcinoma cells and in MDA-MB-231 breast cancer cells and showed a positive cytosolic signal, confirming that this interaction occurs in human cells. This is the first report of a protein-protein interaction involving cN-II, suggesting either novel functions or an additional level of regulation of this complex enzyme.

[1]  P. L. Ipata,et al.  The functional logic of cytosolic 5'-nucleotidases. , 2013, Current medicinal chemistry.

[2]  R. Pesi,et al.  On the physiological role of cytosolic 5'-nucleotidase II (cN-II): pathological and therapeutical implications. , 2013, Current medicinal chemistry.

[3]  Yongjin Park,et al.  The Housekeeping Gene Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) Regulates Multiple Developmental and Metabolic Pathways of Murine Embryonic Stem Cell Neuronal Differentiation , 2013, PloS one.

[4]  F. Martinon,et al.  Crystal Structure of NLRC4 Reveals Its Autoinhibition Mechanism , 2013, Science.

[5]  Fabien Zoulim,et al.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases , 2013, Nature Reviews Drug Discovery.

[6]  A. Galli,et al.  Expression of Bovine Cytosolic 5′-Nucleotidase (cN-II) in Yeast: Nucleotide Pools Disturbance and Its Consequences on Growth and Homologous Recombination , 2013, PloS one.

[7]  W. Evans,et al.  Relapse specific mutations in NT5C2 in childhood acute lymphoblastic leukemia , 2013, Nature Genetics.

[8]  A. Ferrando,et al.  Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL , 2013, Nature Medicine.

[9]  E. Huizinga,et al.  Formation and Structure of a NAIP5-NLRC4 Inflammasome Induced by Direct Interactions with Conserved N- and C-terminal Regions of Flagellin* , 2012, The Journal of Biological Chemistry.

[10]  Theodore Friedmann,et al.  Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase , 2012, Proceedings of the National Academy of Sciences.

[11]  Theodore Friedmann,et al.  MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease? , 2012, Human molecular genetics.

[12]  Hao Xu,et al.  The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus , 2011, Nature.

[13]  V. Radha,et al.  NLRC4 (NLR Family, CARD domain containing 4) , 2011 .

[14]  Theodore Friedmann,et al.  HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene? , 2011, PloS one.

[15]  R. Pesi,et al.  Active and regulatory sites of cytosolic 5′‐nucleotidase , 2010, The FEBS journal.

[16]  A. Amer,et al.  Nlrc4/Ipaf/CLAN/CARD12: more than a flagellin sensor. , 2010, The international journal of biochemistry & cell biology.

[17]  V. Radha,et al.  Interaction with Sug1 enables Ipaf ubiquitination leading to caspase 8 activation and cell death. , 2010, The Biochemical journal.

[18]  R. Flavell,et al.  The role of NOD-like Receptors in shaping adaptive immunity. , 2010, Current opinion in immunology.

[19]  Richard Bonneau,et al.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.

[20]  C. Bryant,et al.  Molecular mechanisms involved in inflammasome activation. , 2009, Trends in cell biology.

[21]  M. Garcia-Gil,et al.  Knockdown of cytosolic 5'-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells. , 2008, Biochimica et biophysica acta.

[22]  Gabriel Núñez,et al.  Intracellular NOD-like receptors in host defense and disease. , 2007, Immunity.

[23]  K. Murai,et al.  Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome. , 2007, Leukemia research.

[24]  C. Galmarini What does over-expression of cN-II enzyme signify in haematological malignancies? , 2007, Leukemia research.

[25]  Michael Karin,et al.  Intracellular pattern recognition receptors in the host response , 2006, Nature.

[26]  H. Spencer,et al.  Enforced expression of cytosolic 5′-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection , 2006, Cancer Chemotherapy and Pharmacology.

[27]  J. Mackey,et al.  cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer. , 2005, Lung cancer.

[28]  C. Galmarini,et al.  Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells , 2005, Molecular Cancer Therapeutics.

[29]  C. Dumontet,et al.  Regulation and activity of cytosolic 5′‐nucleotidase II , 2005, FEBS letters.

[30]  T. Kundu,et al.  Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis , 2005, Oncogene.

[31]  A. Scaloni,et al.  Mechanistic studies on bovine cytosolic 5'-nucleotidase II, an enzyme belonging to the HAD superfamily. , 2004, European journal of biochemistry.

[32]  Ruchi M. Newman,et al.  Multiple Roles of CLAN (Caspase-Associated Recruitment Domain, Leucine-Rich Repeat, and NAIP CIIA HET-E, and TP1-Containing Protein) in the Mammalian Innate Immune Response1 , 2004, The Journal of Immunology.

[33]  J. Mackey,et al.  Deoxycytidine kinase and cN‐II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine , 2003, British journal of haematology.

[34]  J. Ting,et al.  Cutting Edge: CATERPILLER: A Large Family of Mammalian Genes Containing CARD, Pyrin, Nucleotide-Binding, and Leucine-Rich Repeat Domains1 , 2002, The Journal of Immunology.

[35]  B. Mitchell,et al.  ATP and phosphate reciprocally affect subunit association of human recombinant High Km 5'-nucleotidase. Role for the C-terminal polyglutamic acid tract in subunit association and catalytic activity. , 2001, European journal of biochemistry.

[36]  A. Scaloni,et al.  Bovine Cytosolic 5′-Nucleotidase Acts through the Formation of an Aspartate 52-Phosphoenzyme Intermediate* , 2001, The Journal of Biological Chemistry.

[37]  S. Srinivasula,et al.  Identification of Ipaf, a Human Caspase-1-activating Protein Related to Apaf-1* , 2001, The Journal of Biological Chemistry.

[38]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[39]  V. Micheli,et al.  Cytosolic 5′‐nucleotidase hyperactivity in erythrocytes of Lesch–Nyhan syndrome patients , 2000, Neuroreport.

[40]  P. Reichard,et al.  Induction of human high K(M) 5'-nucleotidase in cultured 293 cells. , 1999, Experimental cell research.

[41]  P. Reichard,et al.  Human high-Km 5'-nucleotidase effects of overexpression of the cloned cDNA in cultured human cells. , 1999, European journal of biochemistry.

[42]  R. Pesi,et al.  Bovine cytosolic IMP/GMP-specific 5'-nucleotidase: cloning and expression of active enzyme in Escherichia coli. , 1997, The Biochemical journal.

[43]  C. Baiocchi,et al.  The phosphotransferase activity of cytosolic 5'-nucleotidase; a purine analog phosphorylating enzyme. , 1996, The international journal of biochemistry & cell biology.

[44]  M. Turriani,et al.  The bifunctional cytosolic 5'-nucleotidase: regulation of the phosphotransferase and nucleotidase activities. , 1994, Archives of biochemistry and biophysics.

[45]  T. Kipps,et al.  Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. , 1993, Blood.

[46]  F. Sgarrella,et al.  Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 5'-nucleotidase. , 1991, Archives of biochemistry and biophysics.

[47]  V. Madrid-Marina,et al.  High Km soluble 5'-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP. , 1988, The Journal of biological chemistry.

[48]  R Itoh,et al.  Purification and some properties of cytosol 5'-nucleotidase from rat liver. , 1981, Biochimica et biophysica acta.

[49]  F. Sutterwala,et al.  NLRC4/IPAF: a CARD carrying member of the NLR family. , 2009, Clinical immunology.

[50]  R. Schiestl,et al.  High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method , 2007, Nature Protocols.